Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

11C-Methionine PET Identifies Astroglia Involvement in Heart-Brain Inflammation Networking after Acute Myocardial Infarction.

Bascuñana P, Heß A, Borchert T, Wang Y, Wollert KC, Bengel FM, Thackeray JT.

J Nucl Med. 2019 Dec 5. pii: jnumed.119.236885. doi: 10.2967/jnumed.119.236885. [Epub ahead of print]

PMID:
31806766
2.

Crystal structure and receptor-interacting residues of MYDGF - a protein mediating ischemic tissue repair.

Ebenhoch R, Akhdar A, Reboll MR, Korf-Klingebiel M, Gupta P, Armstrong J, Huang Y, Frego L, Rybina I, Miglietta J, Pekcec A, Wollert KC, Nar H.

Nat Commun. 2019 Nov 26;10(1):5379. doi: 10.1038/s41467-019-13343-7.

3.

Multimodality Imaging of Inflammation and Ventricular Remodeling in Pressure Overload Heart Failure.

Glasenapp A, Derlin K, Wang Y, Bankstahl M, Meier M, Wollert KC, Bengel FM, Thackeray JT.

J Nucl Med. 2019 Oct 25. pii: jnumed.119.232488. doi: 10.2967/jnumed.119.232488. [Epub ahead of print]

PMID:
31653713
4.

TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation.

Grund A, Szaroszyk M, Korf-Klingebiel M, Malek Mohammadi M, Trogisch FA, Schrameck U, Gigina A, Tiedje C, Gaestel M, Kraft T, Hegermann J, Batkai S, Thum T, Perrot A, Remedios CD, Riechert E, Völkers M, Doroudgar S, Jungmann A, Bauer R, Yin X, Mayr M, Wollert KC, Pich A, Xiao H, Katus HA, Bauersachs J, Müller OJ, Heineke J.

EMBO Mol Med. 2019 Oct;11(10):e10018. doi: 10.15252/emmm.201810018. Epub 2019 Aug 30.

5.

Heparan Sulfate-Editing Extracellular Sulfatases Enhance VEGF Bioavailability for Ischemic Heart Repair.

Korf-Klingebiel M, Reboll MR, Grote K, Schleiner H, Wang Y, Wu X, Klede S, Mikhed Y, Bauersachs J, Klintschar M, Rudat C, Kispert A, Niessen HW, Lübke T, Dierks T, Wollert KC.

Circ Res. 2019 Oct 11;125(9):787-801. doi: 10.1161/CIRCRESAHA.119.315023. Epub 2019 Aug 22.

PMID:
31434553
6.

Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy.

Seitz A, Wollert KC, Meyer GP, Müller-Ehmsen J, Tschöpe C, May AE, Empen K, Chorianopoulos E, Ritter B, Pirr J, Arseniev L, Heuft HG, Ganser A, Abu-Zaid E, Katus HA, Felix SB, Gawaz MP, Schultheiss HP, Ladage D, Bauersachs J, Mahrholdt H, Greulich S.

Clin Res Cardiol. 2019 Aug 10. doi: 10.1007/s00392-019-01537-4. [Epub ahead of print]

PMID:
31401672
7.

Iron and atherosclerosis: too much of a good thing can be bad.

Kempf T, Wollert KC.

Eur Heart J. 2019 Jul 19. pii: ehz506. doi: 10.1093/eurheartj/ehz506. [Epub ahead of print] No abstract available.

PMID:
31324916
8.

Levels of Growth Differentiation Factor 15 and Early Mortality Risk Stratification in Cardiogenic Shock.

Hongisto M, Kataja A, Tarvasmäki T, Holopainen A, Javanainen T, Jurkko R, Jäntti T, Kimmoun A, Levy B, Mebazaa A, Pulkki K, Sionis A, Tolppanen H, Wollert KC, Harjola VP, Lassus J; CardShock investigators.

J Card Fail. 2019 Nov;25(11):894-901. doi: 10.1016/j.cardfail.2019.07.003. Epub 2019 Jul 13.

PMID:
31310811
9.

Inactivation of Sox9 in fibroblasts reduces cardiac fibrosis and inflammation.

Scharf GM, Kilian K, Cordero J, Wang Y, Grund A, Hofmann M, Froese N, Wang X, Kispert A, Kist R, Conway SJ, Geffers R, Wollert KC, Dobreva G, Bauersachs J, Heineke J.

JCI Insight. 2019 Jul 16;5. pii: 126721. doi: 10.1172/jci.insight.126721.

10.

The transcription factor GATA4 promotes myocardial regeneration in neonatal mice.

Malek Mohammadi M, Kattih B, Grund A, Froese N, Korf-Klingebiel M, Gigina A, Schrameck U, Rudat C, Liang Q, Kispert A, Wollert KC, Bauersachs J, Heineke J.

EMBO Mol Med. 2019 Jun;11(6). pii: e10678. doi: 10.15252/emmm.201910678. No abstract available.

11.

C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function.

Wang Y, Dembowsky K, Chevalier E, Stüve P, Korf-Klingebiel M, Lochner M, Napp LC, Frank H, Brinkmann E, Kanwischer A, Bauersachs J, Gyöngyösi M, Sparwasser T, Wollert KC.

Circulation. 2019 Apr 9;139(15):1798-1812. doi: 10.1161/CIRCULATIONAHA.118.036053.

12.

Plasma Concentrations of Myeloid-Derived Growth Factor in Healthy Individuals and Patients with Acute Myocardial Infarction as Assessed by Multiple Reaction Monitoring-Mass Spectrometry.

Polten F, Reboll MR, Widera C, Kempf T, Bethmann K, Gupta P, Miglietta J, Pekcec A, Tillmanns J, Bauersachs J, Giannitsis E, Pich A, Wollert KC.

Anal Chem. 2019 Jan 15;91(2):1302-1308. doi: 10.1021/acs.analchem.8b03041. Epub 2018 Dec 28.

PMID:
30543396
13.

Corrigendum to "Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice" Journal of Molecular and Cellular Cardiology 122 (2018) 114-124.

Froese N, Wang H, Zwadlo C, Wang Y, Grund A, Gigina A, Hofmann M, Kilian K, Scharf G, Korf-Klingebiel M, Melchert A, Signorini MER, Halloin C, Zweigerdt R, Martin U, Gruh I, Wollert KC, Geffers R, Bauersachs J, Heineke J.

J Mol Cell Cardiol. 2018 Dec;125:205. doi: 10.1016/j.yjmcc.2018.11.003. Epub 2018 Nov 7. No abstract available.

PMID:
30414408
14.

Growth differentiation factor-15 reveals the dark side of heart failure.

Wollert KC.

Eur J Heart Fail. 2018 Dec;20(12):1710-1712. doi: 10.1002/ejhf.1327. Epub 2018 Oct 17. No abstract available.

15.

Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice.

Froese N, Wang H, Zwadlo C, Wang Y, Grund A, Gigina A, Hofmann M, Kilian K, Scharf G, Korf-Klingebiel M, Melchert A, Signorini MER, Halloin C, Zweigerdt R, Martin U, Gruh I, Wollert KC, Geffers R, Bauersachs J, Heineke J.

J Mol Cell Cardiol. 2018 Sep;122:114-124. doi: 10.1016/j.yjmcc.2018.08.011. Epub 2018 Aug 14. Erratum in: J Mol Cell Cardiol. 2018 Dec;125:205.

PMID:
30118791
16.

A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.

Grund A, Szaroszyk M, Döppner JK, Malek Mohammadi M, Kattih B, Korf-Klingebiel M, Gigina A, Scherr M, Kensah G, Jara-Avaca M, Gruh I, Martin U, Wollert KC, Gohla A, Katus HA, Müller OJ, Bauersachs J, Heineke J.

Cardiovasc Res. 2019 Jan 1;115(1):71-82. doi: 10.1093/cvr/cvy154.

PMID:
29931050
17.

Reg3β is associated with cardiac inflammation and provides prognostic information in patients with acute coronary syndrome.

Lörchner H, Widera C, Hou Y, Elsässer A, Warnecke H, Giannitsis E, Hulot JS, Braun T, Wollert KC, Pöling J.

Int J Cardiol. 2018 May 1;258:7-13. doi: 10.1016/j.ijcard.2018.01.043.

PMID:
29544958
18.

Myocardial Inflammation Predicts Remodeling and Neuroinflammation After Myocardial Infarction.

Thackeray JT, Hupe HC, Wang Y, Bankstahl JP, Berding G, Ross TL, Bauersachs J, Wollert KC, Bengel FM.

J Am Coll Cardiol. 2018 Jan 23;71(3):263-275. doi: 10.1016/j.jacc.2017.11.024.

19.

EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) Is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction.

Reboll MR, Korf-Klingebiel M, Klede S, Polten F, Brinkmann E, Reimann I, Schönfeld HJ, Bobadilla M, Faix J, Kensah G, Gruh I, Klintschar M, Gaestel M, Niessen HW, Pich A, Bauersachs J, Gogos JA, Wang Y, Wollert KC.

Circulation. 2017 Nov 7;136(19):1809-1823. doi: 10.1161/CIRCULATIONAHA.117.029980. Epub 2017 Sep 20.

PMID:
28931551
20.

Targeting of Extracellular RNA Reduces Edema Formation and Infarct Size and Improves Survival After Myocardial Infarction in Mice.

Stieger P, Daniel JM, Thölen C, Dutzmann J, Knöpp K, Gündüz D, Aslam M, Kampschulte M, Langheinrich A, Fischer S, Cabrera-Fuentes H, Wang Y, Wollert KC, Bauersachs J, Braun-Dullaeus R, Preissner KT, Sedding DG.

J Am Heart Assoc. 2017 Jun 21;6(6). pii: e004541. doi: 10.1161/JAHA.116.004541.

21.

Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.

Wollert KC, Meyer GP, Müller-Ehmsen J, Tschöpe C, Bonarjee V, Larsen AI, May AE, Empen K, Chorianopoulos E, Tebbe U, Waltenberger J, Mahrholdt H, Ritter B, Pirr J, Fischer D, Korf-Klingebiel M, Arseniev L, Heuft HG, Brinchmann JE, Messinger D, Hertenstein B, Ganser A, Katus HA, Felix SB, Gawaz MP, Dickstein K, Schultheiss HP, Ladage D, Greulich S, Bauersachs J.

Eur Heart J. 2017 Oct 14;38(39):2936-2943. doi: 10.1093/eurheartj/ehx188.

PMID:
28431003
22.

Changes in concentrations of circulating fibroblast activation protein alpha are associated with myocardial damage in patients with acute ST-elevation MI.

Tillmanns J, Fraccarollo D, Galuppo P, Wollert KC, Bauersachs J.

Int J Cardiol. 2017 Apr 1;232:155-159. doi: 10.1016/j.ijcard.2017.01.037. Epub 2017 Jan 5.

PMID:
28082091
23.

Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease.

Wollert KC, Kempf T, Wallentin L.

Clin Chem. 2017 Jan;63(1):140-151. doi: 10.1373/clinchem.2016.255174. Epub 2016 Oct 25. Review.

24.

The transcription factor GATA4 promotes myocardial regeneration in neonatal mice.

Malek Mohammadi M, Kattih B, Grund A, Froese N, Korf-Klingebiel M, Gigina A, Schrameck U, Rudat C, Liang Q, Kispert A, Wollert KC, Bauersachs J, Heineke J.

EMBO Mol Med. 2017 Feb;9(2):265-279. doi: 10.15252/emmm.201606602. Erratum in: EMBO Mol Med. 2019 Jun;11(6):.

25.

Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.

Sinning C, Ojeda F, Wild PS, Schnabel RB, Schwarzl M, Ohdah S, Lackner KJ, Pfeiffer N, Michal M, Blettner M, Munzel T, Kempf T, Wollert KC, Kuulasmaa K, Blankenberg S, Salomaa V, Westermann D, Zeller T.

Clin Res Cardiol. 2017 Jun;106(6):401-410. doi: 10.1007/s00392-016-1066-x. Epub 2016 Dec 21.

PMID:
28004184
26.

Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.

Sinning C, Kempf T, Schwarzl M, Lanfermann S, Ojeda F, Schnabel RB, Zengin E, Wild PS, Lackner KJ, Munzel T, Blankenberg S, Wollert KC, Zeller T, Westermann D.

Int J Cardiol. 2017 Jan 15;227:272-277. doi: 10.1016/j.ijcard.2016.11.110. Epub 2016 Nov 9.

PMID:
27838133
27.

C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure.

Appari M, Breitbart A, Brandes F, Szaroszyk M, Froese N, Korf-Klingebiel M, Mohammadi MM, Grund A, Scharf GM, Wang H, Zwadlo C, Fraccarollo D, Schrameck U, Nemer M, Wong GW, Katus HA, Wollert KC, Müller OJ, Bauersachs J, Heineke J.

Circ Res. 2017 Jan 6;120(1):66-77. doi: 10.1161/CIRCRESAHA.116.309398. Epub 2016 Nov 7.

PMID:
27821723
28.

Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study.

Wallentin L, Lindhagen L, Ärnström E, Husted S, Janzon M, Johnsen SP, Kontny F, Kempf T, Levin LÅ, Lindahl B, Stridsberg M, Ståhle E, Venge P, Wollert KC, Swahn E, Lagerqvist B; FRISC-II study group.

Lancet. 2016 Oct 15;388(10054):1903-1911. doi: 10.1016/S0140-6736(16)31276-4. Epub 2016 Aug 29.

PMID:
27585757
29.

Targeting Amino Acid Metabolism for Molecular Imaging of Inflammation Early After Myocardial Infarction.

Thackeray JT, Bankstahl JP, Wang Y, Wollert KC, Bengel FM.

Theranostics. 2016 Jul 15;6(11):1768-79. doi: 10.7150/thno.15929. eCollection 2016.

30.

Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure.

Haddad S, Wang Y, Galy B, Korf-Klingebiel M, Hirsch V, Baru AM, Rostami F, Reboll MR, Heineke J, Flögel U, Groos S, Renner A, Toischer K, Zimmermann F, Engeli S, Jordan J, Bauersachs J, Hentze MW, Wollert KC, Kempf T.

Eur Heart J. 2017 Feb 1;38(5):362-372. doi: 10.1093/eurheartj/ehw333.

PMID:
27545647
31.

Biomarkers for the prediction of venous thromboembolism in the community.

Puurunen MK, Enserro D, Xanthakis V, Larson MG, Benjamin EJ, Tofler GH, Wollert KC, O'Donnell CJ, Vasan RS.

Thromb Res. 2016 Sep;145:34-9. doi: 10.1016/j.thromres.2016.07.006. Epub 2016 Jul 14.

PMID:
27447083
32.

Prevalence, Neurohormonal Correlates, and Prognosis of Heart Failure Stages in the Community.

Xanthakis V, Enserro DM, Larson MG, Wollert KC, Januzzi JL, Levy D, Aragam J, Benjamin EJ, Cheng S, Wang TJ, Mitchell GF, Vasan RS.

JACC Heart Fail. 2016 Oct;4(10):808-815. doi: 10.1016/j.jchf.2016.05.001. Epub 2016 Jul 6.

33.

Follistatin-Like 1: Growing Evidence for Its Beneficial Role in Heart Failure.

Wollert KC.

JACC Basic Transl Sci. 2016 Jun 27;1(4):222-223. doi: 10.1016/j.jacbts.2016.05.001. eCollection 2016 Jun. No abstract available.

34.

Corrigendum: Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction.

Korf-Klingebiel M, Reboll MR, Klede S, Brod T, Pich A, Polten F, Napp LC, Bauersachs J, Ganser A, Brinkmann E, Reimann I, Kempf T, Niessen HW, Mizrahi J, Schönfeld HJ, Iglesias A, Bobadilla M, Wang Y, Wollert KC.

Nat Med. 2016 Apr;22(4):446. doi: 10.1038/nm0416-446c. No abstract available.

PMID:
27050592
35.

Evaluation of Temporal Changes in Cardiovascular Biomarker Concentrations Improves Risk Prediction in an Elderly Population from the Community.

Eggers KM, Kempf T, Larsson A, Lindahl B, Venge P, Wallentin L, Wollert KC, Lind L.

Clin Chem. 2016 Mar;62(3):485-93. doi: 10.1373/clinchem.2015.246876. Epub 2016 Jan 14.

36.

Ischaemic risk and bleeding risk in acute coronary syndrome: still inseparable.

Wollert KC.

Eur Heart J. 2016 Apr 21;37(16):1334-6. doi: 10.1093/eurheartj/ehv638. Epub 2015 Dec 8. No abstract available.

PMID:
26646700
37.

Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction.

Thackeray JT, Derlin T, Haghikia A, Napp LC, Wang Y, Ross TL, Schäfer A, Tillmanns J, Wester HJ, Wollert KC, Bauersachs J, Bengel FM.

JACC Cardiovasc Imaging. 2015 Dec;8(12):1417-1426. doi: 10.1016/j.jcmg.2015.09.008. Epub 2015 Nov 11.

38.

Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.

Sinning JM, Wollert KC, Sedaghat A, Widera C, Radermacher MC, Descoups C, Hammerstingl C, Weber M, Stundl A, Ghanem A, Widder J, Vasa-Nicotera M, Mellert F, Schiller W, Bauersachs J, Zur B, Holdenrieder S, Welz A, Grube E, Pencina MJ, Nickenig G, Werner N, Kempf T.

Am Heart J. 2015 Oct;170(4):821-9. doi: 10.1016/j.ahj.2015.07.003. Epub 2015 Jul 10.

PMID:
26386807
39.

Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke.

Andersson C, Preis SR, Beiser A, DeCarli C, Wollert KC, Wang TJ, Januzzi JL Jr, Vasan RS, Seshadri S.

Stroke. 2015 Sep;46(9):2568-75. doi: 10.1161/STROKEAHA.115.009026. Epub 2015 Jul 28.

40.

Bone marrow mononuclear cell therapy for acute myocardial infarction: we know what we want, but we just don't know how yet.

Wollert KC.

Heart. 2015 Mar;101(5):337-8. doi: 10.1136/heartjnl-2014-306787. Epub 2015 Jan 18. No abstract available.

PMID:
25601817
41.

Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction.

Korf-Klingebiel M, Reboll MR, Klede S, Brod T, Pich A, Polten F, Napp LC, Bauersachs J, Ganser A, Brinkmann E, Reimann I, Kempf T, Niessen HW, Mizrahi J, Schönfeld HJ, Iglesias A, Bobadilla M, Wang Y, Wollert KC.

Nat Med. 2015 Feb;21(2):140-9. doi: 10.1038/nm.3778. Epub 2015 Jan 12. Erratum in: Nat Med. 2016 Apr;22(4):446.

PMID:
25581518
42.

Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction.

Bär C, Bernardes de Jesus B, Serrano R, Tejera A, Ayuso E, Jimenez V, Formentini I, Bobadilla M, Mizrahi J, de Martino A, Gomez G, Pisano D, Mulero F, Wollert KC, Bosch F, Blasco MA.

Nat Commun. 2014 Dec 18;5:5863. doi: 10.1038/ncomms6863.

43.

Clinically relevant strategies for lowering cardiomyocyte glucose uptake for 18F-FDG imaging of myocardial inflammation in mice.

Thackeray JT, Bankstahl JP, Wang Y, Wollert KC, Bengel FM.

Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):771-80. doi: 10.1007/s00259-014-2956-7. Epub 2014 Nov 12.

PMID:
25389013
44.

Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study.

Xanthakis V, Enserro DM, Murabito JM, Polak JF, Wollert KC, Januzzi JL, Wang TJ, Tofler G, Vasan RS.

Circulation. 2014 Nov 4;130(19):1676-83. doi: 10.1161/CIRCULATIONAHA.114.009273. Epub 2014 Oct 1.

PMID:
25274000
45.

Biomarkers of cardiovascular stress and subclinical atherosclerosis in the community.

Gopal DM, Larson MG, Januzzi JL, Cheng S, Ghorbani A, Wollert KC, Kempf T, D'Agostino RB, Polak JF, Ramachandran VS, Wang TJ, Ho JE.

Clin Chem. 2014 Nov;60(11):1402-8. doi: 10.1373/clinchem.2014.227116. Epub 2014 Sep 18.

46.

Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury.

Kapopara PR, von Felden J, Soehnlein O, Wang Y, Napp LC, Sonnenschein K, Wollert KC, Schieffer B, Gaestel M, Bauersachs J, Bavendiek U.

Thromb Haemost. 2014 Dec;112(6):1264-76. doi: 10.1160/TH14-02-0174. Epub 2014 Aug 14.

PMID:
25120198
47.

Targeting post-infarct inflammation by PET imaging: comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model.

Thackeray JT, Bankstahl JP, Wang Y, Korf-Klingebiel M, Walte A, Wittneben A, Wollert KC, Bengel FM.

Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):317-27. doi: 10.1007/s00259-014-2884-6. Epub 2014 Aug 12.

PMID:
25112398
48.

Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.

Damman P, Kempf T, Windhausen F, van Straalen JP, Guba-Quint A, Fischer J, Tijssen JG, Wollert KC, de Winter RJ, Hirsch A; ICTUS investigators.

Int J Cardiol. 2014 Mar 15;172(2):356-63. doi: 10.1016/j.ijcard.2014.01.025. Epub 2014 Jan 23.

PMID:
24502880
49.

Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation.

Rienstra M, Yin X, Larson MG, Fontes JD, Magnani JW, McManus DD, McCabe EL, Coglianese EE, Amponsah M, Ho JE, Januzzi JL Jr, Wollert KC, Fradley MG, Vasan RS, Ellinor PT, Wang TJ, Benjamin EJ.

Am Heart J. 2014 Jan;167(1):109-115.e2. doi: 10.1016/j.ahj.2013.10.003. Epub 2013 Oct 17.

50.

Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling.

Herzog C, Lorenz A, Gillmann HJ, Chowdhury A, Larmann J, Harendza T, Echtermeyer F, Müller M, Schmitz M, Stypmann J, Seidler DG, Damm M, Stehr SN, Koch T, Wollert KC, Conway EM, Theilmeier G.

Cardiovasc Res. 2014 Mar 1;101(3):400-10. doi: 10.1093/cvr/cvt275. Epub 2013 Dec 9.

PMID:
24323314

Supplemental Content

Loading ...
Support Center